About
Tulavi Therapeutics is a development-stage medical device company that specializes in Adaptive Hydrogel Technology aimed at enhancing nerve healing and preventing neuroma formation after peripheral nerve injuries and amputations. Their flagship product, the allay™ Hydrogel Cap, is a fully absorbable and sutureless device that acts as a protective barrier for injured nerves, supporting recovery and reducing the risk of chronic pain. The company is part of a group of MedTech firms supported by Incept, an accelerator with extensive experience in launching medical technology ventures. Tulavi focuses on addressing critical challenges in peripheral nerve surgery, particularly for veterans and patients with traumatic injuries. They have partnered with Veterans Healthcare Supply Solutions to distribute their hydrogel cap to U.S. Department of Veterans Affairs hospitals, expanding access to advanced surgical options for those in need. Led by CEO Josh Vose, MD, MBA, Tulavi promotes a culture of respect, accountability, and integrity, with a commitment to improving patient outcomes and reshaping the future of nerve care.
Technologies
Keywords
Company Information
-
Employees 37
-
Founded 2018
Location
160 Knowles Dr, Los Gatos, California, United States, 95032-1828